̽»¨¾«Ñ¡

M.D., Ph.D.
Specialist in Internal Medicine and Cardiology
EHRA board member
Chair EHRA Digital Committee
I am combining clinical work as a physicianin the department of Cardiology at
Karolinska University Hospital in Stockholm, Sweden, with research in
arrhythmias. The combination of clinical work and research work ensure that I
always have the patients' interest at heart in my research work.
My main resarch interest is in atrial fibrillation, the most common heart
rhythm disorder world-wide, affection more than 3% of the adult population.
Atrial fibrillation can unfortunately cause stroke, and patients with atrial
fibrillation get more severe strokes compared to patients without atrial
fibrillation. Fortunately, one of the most efficient therapies known in
medicine is available for patients with atrial fibrillation, which is oral
anticoagulant medication. Atrial fibrillation is asymptomatic in about 30% of
patients, hence both patients and doctors might be unaware of the patient
being at risk of a stroke.
The research I have been involved in has mainly been screening for atrial
fibrillation, in order to detect the disease early and try to prevent
strokes.

AF Screen International Collaboration Steering
Committee 2021-

European Heart Rhythm Association (EHRA) - treasurer 2024-

EP Europace Deputy Editor 2023-
European Heart Rhythm Association (EHRA) Chair digital committee 2020-22
EHRA Congress Scientific Programme Committee 2020 -24
European Heart Rhythm Association (EHRA) Board member m-Health
co-ordinator 2018-20
European Society of Cardiology (ESC) Liaison officer Digital Health
Committee 2019-2022

ESC Editorial Board Digital Health 
E-journal
2019-
Heart Rhythm Society (HRS) Digital Health
Committee
2019-2021
President of the Cardiologists of Tomorrow's Swedish
branch
2015-17
The Swedish Society of Cardiology's research award 2015, 2017
Bio̽»¨¾«Ñ¡ education, ̽»¨¾«Ñ¡, 1997-1999
Medical education with research direction, ̽»¨¾«Ñ¡, 1999-2004
PhD dissertation "Screening for atrial fibrillation in high-risk individuals
- a stroke preventive effort", 2016
Research school for clinicians in Epidemiology, ̽»¨¾«Ñ¡, 2014-6
Teaching and learning in higher education, Karolinska Instiutet, 2018
Leading research projects, ̽»¨¾«Ñ¡, 2018

In the Strokestop 1 & 2 studies we have been screening > 14 000 elderly
Swedish residents for atrial fibrillation using protable ECG-devices. By
screening for atrial fibrillation we have detected 3% new atrial fibrillation
in the screened population. Patients with newly detected atrial fibrillation
have been given stroke-protective, oral anticoagulation therapy in > 90% of
cases.
Currently we are starting a new research project to determine if artificial
intelligence can be of use to predict heart rhythm disorders and the
consequences of heart rhythm disorders.